Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention

Figures & data

Figure 1 Kaplan Meier cumulative event rates for primary endpoint at 30 days after PCI in the PCI CURE study. Reprinted from The Lancet, 358, Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, 527–533,¹⁸ Copyright © 2001, with permission from Elsevier.

Figure 2 CREDO combined end points at 28 Days. Reproduced with permission from Steinhubl et al. JAMA. 2002;288(19):2411–2420.¹⁹ Copyright © 2005 American Medical Association. All rights reserved.

Figure 3 Outcomes at 30 days in the PCI-CLARITY study. Reproduced with permission from Sabatine et al. JAMA. 2005;294(10):1224–1232.²⁰ Copyright © 2005 American Medical Association. All rights reserved.

Figure 4 Summary of PCI studies assessing the effect of clopidogrel treatment. Reproduced with permission from Sabatine et al. JAMA. 2005;294(10):1224–1232.²⁰ Copyright © 2005 American Medical Association. All rights reserved.

Figure 5 Meta-analysis of clopidogrel pretreatment in STEMI patients undergoing PCI with respect to short-term outcomes. Reproduced with permission from Vlaar PJ, Svilaas T, Damman K, et al. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review. Circulation. 2008;118(18):1828–1836.²³ Copyright © 2008 Lippincott Williams and Wilkins.

Figure 6 Peri-procedural biomarker changes in the ARMYDA-2 study. Reproduced with permission from Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2005;111(16):2099–2106.²⁷ Copyright © 2005 Lippincott Williams and Wilkins.

Figure 7 Degree of platelet inhibition and major cardiovascular events. Reproduced with permission from Hochholzer W, Trenk D, Bestehorn HP, et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol. 2006;48(9):1742–1750.³⁶ Copyright © 2006 Elsevier.

Figure 8 Effect of additional clopidogrel dosing on VASP Index. Reproduced with permission from Bonello L, Camoin-Jau L, Arques S, et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol. 2008;51(14):1404–1411.⁴¹ Copyright © 2008 Elsevier.

Figure 9 One month clinical outcomes standard versus VASP-guided clopidogrel loading. Reproduced with permission from Bonello L, Camoin-Jau L, Arques S, et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol. 2008;51(14):1404–1411.⁴¹ Copyright © 2008 Elsevier.

MehtaSRYusufSPetersRJEffects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyLancet2001358928152753311520521

 PubMed Web of Science ®Google Scholar

SteinhublSRBergerPBMannJT3rdEarly and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trialJAMA2002288192411242012435254

 PubMed Web of Science ®Google Scholar

SabatineMSCannonCPGibsonCMEffect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY studyJAMA2005294101224123216143698

 PubMed Web of Science ®Google Scholar

VlaarPJSvilaasTDammanKImpact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic reviewCirculation2008118181828183618852370

 PubMed Web of Science ®Google Scholar

PattiGColonnaGPasceriVRandomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) studyCirculation2005111162099210615750189

 PubMed Web of Science ®Google Scholar

HochholzerWTrenkDBestehornHPImpact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placementJ Am Coll Cardiol20064891742175017084243

 PubMed Web of Science ®Google Scholar

BonelloLCamoin-JauLArquesSAdjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective studyJ Am Coll Cardiol200851141404141118387444

 PubMed Web of Science ®Google Scholar